In patients with node negative, ER+, PR+, HER2-neu negative invasive breast cancer who intend to undergo breast conserving surgery by downstaging disease with neoadjuvant therapy, breast-conserving plastic surgery may be needed to obtain negative margins. This evidence concerns the gene ERBB2 and invasive breast carcinoma.